Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aquestive Therapeutics, Inc.

NASDAQ: AQST · Life Sciences · 12 alerts · CIK 1398733

Share price
$3.76Close, Nov 16
Market cap
$473M
Shares outstanding
125.69MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aquestive Therapeutics, Inc. filings on SEC EDGAR ↗

4:20 PM ET 10-Q
Financial Results

Aquestive Therapeutics Q3 2026 Results: Net Loss of $16.5M, Loss Widens

Aquestive Therapeutics reported a net loss of $47.4 million for the nine months ended September 30, 2026, compared to a loss of $54.9 million in the prior year period. Total revenues increased to $35.8 million from $31.5 million, while the company recognized a $11.7 million loss on the extinguishment of debt following the redemption of its 13.5% Notes.

Key figure
Net loss $16.5M
4:17 PM ET 8-K
Financial Results

Aquestive Therapeutics Financial Results

Aquestive Therapeutics reported Q3 2026 financial results and provided a regulatory update for its lead candidate Anaphylm, which has a PDUFA goal date of March 16, 2027. The company is preparing for a potential U.S. launch and plans to submit regulatory filings in Canada and the EU in late 2026 and early 2027.

Term
Q3 2026

“With a PDUFA goal date of March 16, 2027, we believe we have a clear path to making Anaphylm available to patients and caregivers, if approved. For decades, people at risk of anaphylaxis have had limited treatment options. We believe Anaphylm - designed to be easy to carry and use confidently whenever and wherever it may be needed - has the potential to address important unmet needs.”

Daniel Barber, President and Chief Executive Officer of Aquestive

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.